DiscoverAdvances in CareCracking the Code: Sequencing the Hodgkin Lymphoma Genome to Uncover New Precision Therapies
Cracking the Code: Sequencing the Hodgkin Lymphoma Genome to Uncover New Precision Therapies

Cracking the Code: Sequencing the Hodgkin Lymphoma Genome to Uncover New Precision Therapies

Update: 2024-05-30
Share

Description

In 2012, Dr. Lisa Roth had just landed her dream job as a research scientist and attending physician at NewYork-Presbyterian and Weill Cornell Medicine. But her world came to a screeching halt when she discovered a swollen lymph node on her neck, and was soon diagnosed with the exact type of cancer that she had dedicated her career to studying and treating: Hodgkin Lymphoma. After that experience, Dr. Roth was more determined than ever to uncover the biology of this notoriously difficult to study cancer. Dr. Roth, now Director of Pediatric Oncology and Associate Professor in the Departments of Pediatrics, Medicine and Pathology and Laboratory Medicine at NewYork-Presbyterian and Weill Cornell Medicine, tells the story of how she and her team became the first researchers to sequence the entire Hodgkin Lymphoma genome, opening doors for precision and preventative treatment options.

For more information visit nyp.org/Advances

Comments (1)

Akhtar Hussain

3luckyblue game Pakistan Game ( https://www.3luckybluee.com/)

Mar 8th
Reply
In Channel
Advances in Care

Advances in Care

2024-01-1802:20

loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Cracking the Code: Sequencing the Hodgkin Lymphoma Genome to Uncover New Precision Therapies

Cracking the Code: Sequencing the Hodgkin Lymphoma Genome to Uncover New Precision Therapies

Dr. Lisa Roth, Catherine Price

We and our partners use cookies to personalize your experience, to show you ads based on your interests, and for measurement and analytics purposes. By using our website and our services, you agree to our use of cookies as described in our Cookie Policy.